L. Kim et al., White-matter abnormalities in unirradiated patients cured of primary central nervous system lymphoma, NEURORADIOL, 42(6), 2000, pp. 406-412
On MRI, primary brain tumors are commonly seen as contrast-enhancing masses
surrounded by areas of abnormal signal on T2-weighted images. Following su
ccessful treatment tumors may no longer show contrast enhancement. The resi
dual abnormalities are assumed to be represent "edema" and infiltrating tum
or cells. We report nine patients with primary lymphoma of the central nerv
ous system who had complete responses to intravenous methotrexate, but did
not receive intrathecal chemotherapy or cranial irradiation. After complete
resolution of contrast-enhancing lesions, persistent abnormalities on T2-w
eighted images in the region of prior tumor were initially assumed to refle
ct residual viable tumor. As they remained unchanged for years, however, th
is may not hold true in the cases in which primary central nervous system l
ymphoma responds to chemotherapy alone.